Table 2.

Effect of GANMO on lipid levels in cholesterol-induced dyslipidemia after 2 weeks of treatment.

Groups/treatment 2nd week	n	TG ($\overline{X}$ ± SD)	TC ($\overline{X}$ ± SD)	HDL-C ($\overline{X}$ ± SD)	LDL-C ($\overline{X}$ ± SD)
Control group	10	0.50 ± 0.11	2.16 ± 0.15	1.08 ± 0.15	0.85 ± 0.22
Model group	10	0.54 ± 0.17	2.38 ± 0.35	1.16 ± 0.20	1.11 ± 0.19∗
Atorvastatin (10 mg/kg)	10	0.49 ± 0.12	2.36 ± 0.29	1.06 ± 0.16	1.08 ± 0.34
GANMO (15.1 g/kg)	10	0.74 ± 0.25	2.66 ± 0.28	1.05 ± 0.22	1.27 ± 0.46
GANMO (45.3 g/kg)	10	0.45 ± 0.14	2.56 ± 0.33	0.99 ± 0.17	1.37 ± 0.40